等待开盘 02-07 09:30:00 美东时间
+2.510
+6.15%
Par Pacific Holdings Inc. kündigt Veröffentlichung von Finanzergebnissen und Investorenkonferenz an Par Pacific Holdings Inc. wird die Ergebnisse für das vierte Quartal 2025 am Dienstag, den 24. Februar 2026, nach Börsenschluss veröffentlichen. Die vollständige Mitteilung wird auf der Unternehmenswe
02-04 05:15
As earnings season ramps up and geopolitical tensions keep affecting the markets, below is a list of the top 15 energy stocks that are widely regarded as cheap high flyer stocks according to SA gradin...
02-02 22:27
今日重点评级关注:HC Wainwright & Co.:维持Enlivex Therapeutics"买入"评级,目标价从7美元升至13美元;BTIG:维持Oruka Therapeutics"买入"评级,目标价从63美元升至73美元
01-13 10:18
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Par Pacific Holdings Inc : JP Morgan Cuts Target Price to $42 From $50
01-09 12:34
Piper Sandler analyst Ryan Todd maintains Par Pacific Hldgs (NYSE:PARR) with a Overweight and lowers the price target from $62 to $59.
01-08 23:01
The most oversold stocks in the energy sector presents an opportunity to buy in...
01-02 19:05
HOUSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) announced its 2026 capital expenditure and turnaround outlay guidance of $190 million to $220 million. This includes $50-$60 million for turnarounds, $105-$115 million for maintenance and catalysts, and $35-$45 million for growth. The company is based in Houston and operates in renewable and conventional fuels. For more information, contact Ashimi Patel Vitter at (...
2025-12-22 13:00
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
Mizuho analyst Nitin Kumar maintains Par Pacific Hldgs (NYSE:PARR) with a Neutral and raises the price target from $45 to $49.
2025-12-12 20:50